K Hieke

Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

Chris Twelves, Michael Boyer, Michael Findlay et al. · European Journal of Cancer · 2001 · 159 citations

5-Fluorouracil Plus Leucovorin, Gastrointestinal Oncology, Medicine +9

Anxiety and Depression Prevalence Rates in Age-Related Macular Degeneration

Albert J. Augustin, José‐Alain Sahel, Francesco Bandello et al. · Investigative Ophthalmology & Visual Science · 2007 · 141 citations · Full text

Cost of illness from occupational hand eczema in Germany

Thomas L. Diepgen, Reginald Scheidt, Swen Malte John et al. · Contact Dermatitis · 2013 · 115 citations

Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries

A Lafuma, Antoine Br zin, Stefania Lopatriello et al. · PharmacoEconomics · 2006 · 69 citations

Ophthalmology, Health Economics, Health Policy +11

An Economic Evaluation of Cetuximab Combined with Radiotherapy for Patients with Locally Advanced Head and Neck Cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

Ben Brown, Jacques Bernier, Patrick Schöffski et al. · Value in Health · 2008 · 63 citations · Full text

Oncology, Radiation Therapy, Cancer Management +9